Anti-ELMO3 monoclonal antibody

Pre-made anti-ELMO3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ELMO3/ELMO3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2472-Ab-1/ GM-Tg-hg-IP2472-Ab-2Anti-Human ELMO3 monoclonal antibodyHuman
GM-Tg-rg-IP2472-Ab-1/ GM-Tg-rg-IP2472-Ab-2Anti-Rat ELMO3 monoclonal antibodyRat
GM-Tg-mg-IP2472-Ab-1/ GM-Tg-mg-IP2472-Ab-2Anti-Mouse ELMO3 monoclonal antibodyMouse
GM-Tg-cynog-IP2472-Ab-1/ GM-Tg-cynog-IP2472-Ab-2Anti-Cynomolgus/ Rhesus macaque ELMO3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2472-Ab-1/ GM-Tg-felg-IP2472-Ab-2Anti-Feline ELMO3 monoclonal antibodyFeline
GM-Tg-cang-IP2472-Ab-1/ GM-Tg-cang-IP2472-Ab-2Anti-Canine ELMO3 monoclonal antibodyCanine
GM-Tg-bovg-IP2472-Ab-1/ GM-Tg-bovg-IP2472-Ab-2Anti-Bovine ELMO3 monoclonal antibodyBovine
GM-Tg-equg-IP2472-Ab-1/ GM-Tg-equg-IP2472-Ab-2Anti-Equine ELMO3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2472-Ab-1/ GM-Tg-hg-IP2472-Ab-2; GM-Tg-rg-IP2472-Ab-1/ GM-Tg-rg-IP2472-Ab-2;
GM-Tg-mg-IP2472-Ab-1/ GM-Tg-mg-IP2472-Ab-2; GM-Tg-cynog-IP2472-Ab-1/ GM-Tg-cynog-IP2472-Ab-2;
GM-Tg-felg-IP2472-Ab-1/ GM-Tg-felg-IP2472-Ab-2; GM-Tg-cang-IP2472-Ab-1/ GM-Tg-cang-IP2472-Ab-2;
GM-Tg-bovg-IP2472-Ab-1/ GM-Tg-bovg-IP2472-Ab-2; GM-Tg-equg-IP2472-Ab-1/ GM-Tg-equg-IP2472-Ab-2
Products NameAnti-ELMO3 monoclonal antibody
Formatmab
Target NameELMO3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ELMO3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2472-Ag-1Recombinant multi-species ELMO3/ CED-12/ CED12 protein
    ORF Viral VectorpGMLPm003125mouse Elmo3 Lentivirus plasmid
    ORF Viral VectorvGMLPm003125mouse Elmo3 Lentivirus particle


    Target information

    Target IDGM-IP2472
    Target NameELMO3
    Gene ID79767,234683,291962,698664,489763,101098506,525427,100065878
    Gene Symbol and Synonyms9930107J06,CED-12,CED12,ELMO-3,ELMO3
    Uniprot AccessionQ96BJ8,Q499U2,A6QR40
    Uniprot Entry NameELMO3_HUMAN,ELMO3_RAT,ELMO3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102890
    Target ClassificationN/A

    The target: ELMO3, gene name: ELMO3, also named as CED-12, CED12, ELMO-3. The protein encoded by this gene is similar to a C. elegans protein that functions in phagocytosis of apoptotic cells and in cell migration. Other members of this small family of engulfment and cell motility (ELMO) proteins have been shown to interact with the dedicator of cyto-kinesis 1 protein to promote phagocytosis and effect cell shape changes. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.